PhRMA picks new president, CEO
Pharmaceutical Research and Manufacturers of America (PhRMA) has named John Castellani its new president and chief executive officer, effective September 1.
Latest
Merck to eliminate eight research facilities
Merck & Co. is planning to phase out operations at eight research sites and eight manufacturing sites. It is also continuing to consolidate office facilities worldwide as part of the global merger restructuring program that began last December following its acquisition of Schering-Plough Corp.
British Columbia cuts generic drug prices
The provincial government will cut generic drug prices by reducing rebates manufacturers pay to pharmacies, including British Columbia-based London Drugs and Pharmasave.
Standley moves quickly to fill COO’s post at Rite Aid
A day after Rite Aid Corp. chief operating officer John Standley took the reins as the drug chain’s president and chief executive officer, the company named senior executive vice president of merchandising, marketing and logistics Ken Martindale as its new chief operating officer.
Walgreens poised to bolster food offerings
Later this summer Walgreen Co. plans to give its customers a taste of Duane Reade’s successful private label program as it continues to ramp up its food offering.
MTM legislation wins support from Rx groups
Building on the pharmacy-specific provisions in the health care reform law, the National Association of Chain Drug Stores and the National Community Pharmacists Association (NCPA) have endorsed medication therapy management (MTM) legislation. The MTM bill was authored and introduced by Sen.
Walmart shifts key U.S. executives
Walmart has made several changes in its management ranks in recent weeks. The biggest of those changes has been the appointment of Walmart U.S. chief operating officer Bill Simon to president and chief executive officer of the domestic unit.
Pharmasave, Rx PharmaChoice team up
The Canadian drug chains Pharmasave and Rx PharmaChoice have formed a strategic alliance that executives say will strengthen both companies.
Obama bypasses Senate to fill top CMS post
After the confirmation of President Obama’s choice to run the Centers for Medicare and Medicaid Services (CMS) was held up for nearly three months by Republicans, the president bypassed the legislators earlier this month and appointed Donald Berwick to the post while the Senate was on its summer rec
Jean Coutu mulls drug reform impact
Jean Coutu Group, which posted increased profit in the first quarter, is waiting to see how provincial drug reform will affect its future earnings. Coutu posted a profit of $43.2 million (Canadian) for the fiscal quarter ended May 29, an increase of 12.2% compared with the prior-year period.
NCPA, Chain Drug Consortium form new partnership
The National Community Pharmacists Association (NCPA) and the Chain Drug Consortium (CDC) have formed a collaboration that they say will leverage the strengths of each organization and advance the interests of community pharmacists and their patients.
New private label line launched by Rite Aid
Rite Aid Corp. has launched the latest phase of its revamped private label program with the debut of Simplify, a store brand aimed at price-sensitive shoppers.
Implementation of health care reform act proceeds
Health care reform is being viewed more favorably following the Obama administration’s rollout of multiple regulations laying the groundwork for the law’s implementation.
Big three drug chains are being reshaped
Walgreen Co., CVS Caremark Corp. and Rite Aid Corp. — announced game-changing alterations. In that short span of time Walgreens acquired Duane Reade; Rite Aid reported that Mary Sammons, the retailer’s iconic chief executive,
CVS Caremark keeps eye on what’s next
CVS Caremark recently issued “Insights 2010: Evolving Pharmacy Care,” the latest in a series of annual reports about the role of prescription drugs in the nation’s health care system as seen from the perspective of the company’s pharmacy benefits management operation.
